Journal article · 2010 · Open access
Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,
Biochemistry, 49(8), 1616–1627 · Published 17 January 2010 · DOI 10.1021/bi9016186
In brief
“Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,” is a 2010 journal article by Ruslana Bryk and 7 co-authors, published in Biochemistry. OpenAlex counts 35 citations as of 21 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).
- Citations
- 35
- Most cited in
- 2017 (5)
- Field-weighted impact
- 1.24
- References
- 46
- Authors
- 8
Abstract
Mycobacterium tuberculosis (Mtb) remains the leading single cause of death from bacterial infection. Here we explored the possibility of species-selective inhibition of lipoamide dehydrogenase (Lpd), an enzyme central to Mtb's intermediary metabolism and antioxidant defense. High-throughput screening of combinatorial chemical libraries identified triazaspirodimethoxybenzoyls as high-nanomolar inhibitors of Mtb's Lpd that were noncompetitive versus NADH, NAD(+), and lipoamide and >100-fold selective compared to human Lpd. Efficacy required the dimethoxy and dichlorophenyl groups. The structure of an Lpd-inhibitor complex was resolved to 2.42 A by X-ray crystallography, revealing that the inhibitor occupied a pocket adjacent to the Lpd NADH/NAD(+) binding site. The inhibitor did not overlap with the adenosine moiety of NADH/NAD(+) but did overlap with positions predicted to bind the nicotinamide rings in NADH and NAD(+) complexes. The dimethoxy ring occupied a deep pocket adjacent to the FAD flavin ring where it would block coordination of the NADH nicotinamide ring, while the dichlorophenyl group occupied a more exposed pocket predicted to coordinate the NAD(+) nicotinamide. Several residues that are not conserved between the bacterial enzyme and its human homologue were predicted to contribute both to inhibitor binding and to species selectivity, as confirmed for three residues by analysis of the corresponding mutant Mtb Lpd proteins. Thus, nonconservation of residues lining the electron-transfer tunnel in Mtb Lpd can be exploited for development of species-selective Lpd inhibitors.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bryk, R., Arango, N., Venugopal, A., Warren, J. D., Park, Y., Patel, M. S., Lima, C. D., & Nathan, C. (2010). Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,. Biochemistry, 49(8), 1616–1627. https://doi.org/10.1021/bi9016186
MLA 9
Bryk, Ruslana, et al. “Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,.” Biochemistry, vol. 49, no. 8, 2010, pp. 1616–1627. https://doi.org/10.1021/bi9016186.
Chicago
Bryk, Ruslana, Nancy Arango, Aditya Venugopal, J. David Warren, Yun‐Hee Park, Mulchand S. Patel, Christopher D. Lima, and Carl Nathan. 2010. “Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,.” Biochemistry 49 (8): 1616–1627. https://doi.org/10.1021/bi9016186.
Harvard
Bryk, R. et al. (2010) ‘Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,’, Biochemistry, 49(8), pp. 1616–1627. doi:10.1021/bi9016186.
IEEE
R. Bryk et al., “Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,,” Biochemistry, vol. 49, no. 8, pp. 1616–1627, 2010, doi: 10.1021/bi9016186.
BibTeX
@article{bryk2010triazaspirodimethoxybenzoyls,
title = {{Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,}},
author = {Bryk, Ruslana and Arango, Nancy and Venugopal, Aditya and Warren, J. David and Park, Yun‐Hee and Patel, Mulchand S. and Lima, Christopher D. and Nathan, Carl},
journal = {Biochemistry},
year = {2010},
volume = {49},
number = {8},
pages = {1616--1627},
doi = {10.1021/bi9016186},
url = {https://doi.org/10.1021/bi9016186}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2016 | 2 | |
| 2017 | 5 | |
| 2018 | 2 | |
| 2019 | 2 | |
| 2020 | 1 | |
| 2021 | 1 | |
| 2023 | 2 | |
| 2024 | 1 | |
| 2025 | 4 | |
| 2026 | 1 |
Its field-weighted citation impact is 1.24: it has been cited 1.24 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- lipoamide dehydrogenase
- Mycobacterium tuberculosis
- non-competitive inhibition
- structure-activity relationship
- tuberculosis drug development
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Bryk, R., Arango, N., Venugopal, A., Warren, J. D., Park, Y., Patel, M. S., Lima, C. D., & Nathan, C. (2010). Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase,. Biochemistry, 49(8), 1616–1627. https://doi.org/10.1021/bi9016186
How many times has this paper been cited?
35 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.
Who wrote this paper?
Ruslana Bryk, Nancy Arango, Aditya Venugopal, J. David Warren, Yun‐Hee Park, Mulchand S. Patel, Christopher D. Lima, Carl Nathan.
What is the DOI of this paper?
10.1021/bi9016186, permanently at https://doi.org/10.1021/bi9016186. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.